308 related articles for article (PubMed ID: 26164770)
1. More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life.
Andela CD; Biermasz NR; Kaptein AA; Pereira AM; Tiemensma J
Growth Horm IGF Res; 2015 Oct; 25(5):219-26. PubMed ID: 26164770
[TBL] [Abstract][Full Text] [Related]
2. Patients with adrenal insufficiency hate their medication: concerns and stronger beliefs about the necessity of hydrocortisone intake are associated with more negative illness perceptions.
Tiemensma J; Andela CD; Pereira AM; Romijn JA; Biermasz NR; Kaptein AA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3668-76. PubMed ID: 25226291
[TBL] [Abstract][Full Text] [Related]
3. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
[TBL] [Abstract][Full Text] [Related]
4. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test.
Tiemensma J; Pereira AM; Romijn JA; Broadbent E; Biermasz NR; Kaptein AA
Eur J Endocrinol; 2015 May; 172(5):583-93. PubMed ID: 25724922
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acromegaly improves quality of life, measured by AcroQol.
Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
[TBL] [Abstract][Full Text] [Related]
6. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.
Hua SC; Yan YH; Chang TC
Eur J Endocrinol; 2006 Dec; 155(6):831-7. PubMed ID: 17132752
[TBL] [Abstract][Full Text] [Related]
7. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
[TBL] [Abstract][Full Text] [Related]
8. Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.
Postma MR; Netea-Maier RT; van den Berg G; Homan J; Sluiter WJ; Wagenmakers MA; van den Bergh AC; Wolffenbuttel BH; Hermus AR; van Beek AP
Eur J Endocrinol; 2012 Apr; 166(4):585-92. PubMed ID: 22250074
[TBL] [Abstract][Full Text] [Related]
9. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.
Vandeva S; Yaneva M; Natchev E; Elenkova A; Kalinov K; Zacharieva S
Endocrine; 2015 Aug; 49(3):774-82. PubMed ID: 25561370
[TBL] [Abstract][Full Text] [Related]
10. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome.
Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
Eur J Endocrinol; 2011 Oct; 165(4):527-35. PubMed ID: 21798958
[TBL] [Abstract][Full Text] [Related]
11. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
Webb SM; Badia X; Surinach NL;
Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
[TBL] [Abstract][Full Text] [Related]
12. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.
Kyriakakis N; Lynch J; Gilbey SG; Webb SM; Murray RD
Clin Endocrinol (Oxf); 2017 Jun; 86(6):806-815. PubMed ID: 28316090
[TBL] [Abstract][Full Text] [Related]
13. Self-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: A cross-sectional survey.
De Smedt RH; Denig P; van der Meer K; Haaijer-Ruskamp FM; Jaarsma T
Int J Nurs Stud; 2011 Dec; 48(12):1540-50. PubMed ID: 21774932
[TBL] [Abstract][Full Text] [Related]
14. Illness Perceptions are Associated with Quality of Life in Patients with Fibrous Dysplasia.
Majoor BCJ; Andela CD; Quispel CR; Rotman M; Dijkstra PDS; Hamdy NAT; Kaptein AA; Appelman-Dijkstra NM
Calcif Tissue Int; 2018 Jan; 102(1):23-31. PubMed ID: 29022055
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
[TBL] [Abstract][Full Text] [Related]
17. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
[TBL] [Abstract][Full Text] [Related]
18. Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis.
Hayward KL; Valery PC; Martin JH; Karmakar A; Patel PJ; Horsfall LU; Tallis CJ; Stuart KA; Wright PL; Smith DD; Irvine KM; Powell EE; Cottrell WN
World J Gastroenterol; 2017 Oct; 23(40):7321-7331. PubMed ID: 29142479
[TBL] [Abstract][Full Text] [Related]
19. Patients' illness schemata of hypertension: the role of beliefs for the choice of treatment.
Figueiras M; Marcelino DS; Claudino A; Cortes MA; Maroco J; Weinman J
Psychol Health; 2010 Apr; 25(4):507-17. PubMed ID: 20204931
[TBL] [Abstract][Full Text] [Related]
20. Illness and treatment cognitions and health related quality of life in end stage renal disease.
Griva K; Jayasena D; Davenport A; Harrison M; Newman SP
Br J Health Psychol; 2009 Feb; 14(Pt 1):17-34. PubMed ID: 18435864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
